News Janssen celebrates positive results for JNJ-2113 in psoriasi... Janssen, a Johnson & Johnson company,
Views & Analysis Patient Insights: Severe psoriasis & eczema Howard Chang has lived with severe psoriasis and atopic dermatitis for almost 40 years since childhood.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.